1.12
price down icon1.75%   -0.02
pre-market  시장 영업 전:  1.14   0.02   +1.79%
loading
전일 마감가:
$1.14
열려 있는:
$1.16
하루 거래량:
180.85K
Relative Volume:
0.07
시가총액:
$12.06M
수익:
-
순이익/손실:
$-11.66M
주가수익비율:
-0.1373
EPS:
-8.156
순현금흐름:
$-11.09M
1주 성능:
-14.50%
1개월 성능:
-29.11%
6개월 성능:
-54.66%
1년 성능:
-60.99%
1일 변동 폭
Value
$1.12
$1.17
1주일 범위
Value
$1.07
$1.31
52주 변동 폭
Value
$0.9657
$9.79

Phio Pharmaceuticals Corp Stock (PHIO) Company Profile

Name
명칭
Phio Pharmaceuticals Corp
Name
전화
(508) 767-3861
Name
주소
411 SWEDELAND ROAD, KING OF PRUSSIA, MA
Name
직원
5
Name
트위터
@phio_pharma
Name
다음 수익 날짜
2024-11-07
Name
최신 SEC 제출 서류
Name
PHIO's Discussions on Twitter

PHIO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
PHIO
Phio Pharmaceuticals Corp
1.12 12.27M 0 -11.66M -11.09M -8.156
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.04 113.14B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
741.29 78.49B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ARGX
Argen X Se Adr
877.94 54.76B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
397.55 54.51B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
INSM
Insmed Inc
197.01 41.64B 447.02M -1.18B -906.14M -6.1812

Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-06-05 재개 H.C. Wainwright Buy
2020-08-05 개시 H.C. Wainwright Buy

Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스

pulisher
Dec 06, 2025

EBIT per share of Phio Pharmaceuticals Corp. – BER:44R1 - TradingView

Dec 06, 2025
pulisher
Dec 05, 2025

Will Phio Pharmaceuticals Corp. (44R1) stock beat revenue estimatesMarket Performance Summary & Risk Managed Trade Strategies - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

How Phio Pharmaceuticals Corp. (44R1) stock reacts to fiscal policiesJuly 2025 Update & AI Optimized Trading Strategy Guides - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

How Phio Pharmaceuticals Corp. (44R1) stock reacts to new regulationsJuly 2025 Selloffs & High Yield Equity Trading Tips - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

What technical patterns form on Phio Pharmaceuticals Corp. (44R1) stock chartsJuly 2025 Selloffs & High Yield Equity Trading Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Phio Pharmaceuticals Corp. (PHIO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 04, 2025
pulisher
Dec 04, 2025

Will Phio Pharmaceuticals Corp. (44R1) stock rise with strong economyWeekly Trend Summary & Weekly High Return Stock Opportunities - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Phio Pharma (PHIO) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025
pulisher
Dec 02, 2025

How Phio Pharmaceuticals Corp. (44R1) stock compares with market leadersPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

What insider trading reveals about Phio Pharmaceuticals Corp. stockProfit Target & Verified Swing Trading Watchlists - Newser

Dec 02, 2025
pulisher
Dec 02, 2025

Can Phio Pharmaceuticals Corp. stock continue upward trendMarket Sentiment Report & Real-Time Volume Analysis - Newser

Dec 02, 2025
pulisher
Nov 30, 2025

Phio Pharmaceuticals Completes Enrollment for PH-762 Trial - MSN

Nov 30, 2025
pulisher
Nov 30, 2025

Why retail investors pile into Phio Pharmaceuticals Corp. stockLayoff News & Low Drawdown Trading Strategies - BỘ NỘI VỤ

Nov 30, 2025
pulisher
Nov 28, 2025

MSN Money - MSN

Nov 28, 2025
pulisher
Nov 27, 2025

How Phio Pharmaceuticals Corp. stock responds to policy changesMarket Risk Report & Fast Gain Swing Alerts - moha.gov.vn

Nov 27, 2025
pulisher
Nov 26, 2025

TARC Limited Earnings Review What Investors Need to KnowMid Cap Growth Trends & Free Risk Assessment and Control - earlytimes.in

Nov 26, 2025
pulisher
Nov 25, 2025

Phio Pharmaceuticals Completes Enrollment in Phase 1b Trial of PH-762 - TradingView — Track All Markets

Nov 25, 2025
pulisher
Nov 25, 2025

Phio Pharmaceuticals Corp. Announces Completion of Enrollment in Phase 1B Clinical Trial of Intasyl Sirna Lead Compound Ph-762 - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

Phio completes enrollment in Phase 1b trial of skin cancer therapy - Investing.com Australia

Nov 25, 2025
pulisher
Nov 25, 2025

Phio completes enrollment in Phase 1b trial of skin cancer therapy By Investing.com - Investing.com South Africa

Nov 25, 2025
pulisher
Nov 25, 2025

Phio Pharmaceuticals Announces Completion of Enrollment in Phase 1b Clinical Trial of INTASYL siRNA Lead Compound PH-762 - Newsfile

Nov 25, 2025
pulisher
Nov 25, 2025

Phio Pharmaceuticals (NASDAQ: PHIO) Reports PH-762 Data With 6 Complete Responses - Stock Titan

Nov 25, 2025
pulisher
Nov 24, 2025

[Form 4] Phio Pharmaceuticals Corp. Insider Trading Activity - Stock Titan

Nov 24, 2025
pulisher
Nov 24, 2025

It is Poised to be a Bull Market for Phio Pharmaceuticals Corp (PHIO) - Setenews

Nov 24, 2025
pulisher
Nov 24, 2025

What is HC Wainwright’s Forecast for PHIO FY2025 Earnings? - Defense World

Nov 24, 2025
pulisher
Nov 21, 2025

How higher bond yields impact Phio Pharmaceuticals Corp. (44R1) stockJuly 2025 Closing Moves & Smart Swing Trading Alerts - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Developing predictive dashboards with Phio Pharmaceuticals Corp. dataQuarterly Earnings Summary & Reliable Intraday Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Phio Pharmaceuticals Corp files for offering of up to 11.8 million common shares by the Selling StockholdersSEC filing - MarketScreener

Nov 20, 2025
pulisher
Nov 20, 2025

[S-3] Phio Pharmaceuticals Corp. Shelf Registration Statement | PHIO SEC FilingForm S-3 - Stock Titan

Nov 20, 2025
pulisher
Nov 20, 2025

How Phio Pharmaceuticals Corp. (44R1) stock trades under stagflationMarket Activity Recap & AI Optimized Trade Strategies - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Published on: 2025-11-20 05:56:20 - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Phio Pharmaceuticals Corp. stock performs in rate cut cyclesPortfolio Value Summary & Real-Time Stock Entry Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Phio Pharmaceuticals Corp. (44R1) stock protected from inflationJuly 2025 Analyst Calls & Low Risk Investment Opportunities - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How Phio Pharmaceuticals Corp. (44R1) stock trades in high volatilityEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 20:52:55 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 18:13:16 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 16:59:54 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Published on: 2025-11-19 16:50:52 - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How Phio Pharmaceuticals Corp. (44R1) stock correlates with oil marketsDay Trade & Free Risk Controlled Daily Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Insider Buying: Robert Bitterman Acquires Additional Shares of P - GuruFocus

Nov 19, 2025
pulisher
Nov 19, 2025

Bitterman buys Phio Pharmaceuticals (PHIO) stock worth $6350 By Investing.com - Investing.com Canada

Nov 19, 2025
pulisher
Nov 19, 2025

Bitterman buys Phio Pharmaceuticals (PHIO) stock worth $6350 - Investing.com India

Nov 19, 2025

Phio Pharmaceuticals Corp (PHIO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
자본화:     |  볼륨(24시간):